The SFSR was validated for syncope (transient loss of consciousness with complete recovery), not near-syncope (almost blacking out without true LOC). However, the distinction between syncope and near-syncope is often blurry based on patient report. Most experts recommend applying the same risk stratification approach to near-syncope given its similar pathophysiology and outcome risk, though SFSR's performance is less established in this group.

If you cannot obtain a prior ECG for comparison and the current ECG shows any abnormality, err on the side of calling it abnormal. The downside of falsely calling a low-risk patient high-risk (unnecessary admission) is preferable to missing a high-risk arrhythmia in a truly abnormal ECG. If a prior ECG showing identical findings is available, the abnormality can be classified as chronic.

No. SFSR is a risk stratification aid, not a mandate. Clinical gestalt, mechanism of loss of consciousness, age, comorbidities, social support, and ability to follow up all contribute to the disposition decision. A frail elderly patient with multiple prior syncopal episodes and poor social support who barely meets 'all CHESS negative' may warrant admission or extended observation despite the low-risk classification.

Check orthostatic vitals regardless of CHESS status — they provide critical mechanistic information. In a CHESS-positive patient (e.g., CHF history), orthostatic hypotension identifies a potentially reversible cause (overdiuresis, dehydration) that can be treated and may prevent recurrence. In CHESS-negative patients, significant orthostasis identifies a cause and guides disposition.

Yes — hematocrit <30% is positive regardless of whether anemia is acute or chronic. However, the clinical significance differs: acute GI bleeding causing Hct <30% warrants aggressive workup; chronic stable anemia at the same level represents baseline. Use your judgment on urgency of the anemia workup, but the criterion still applies to CHESS scoring.